Farmacopea De Los Estados Unidos Mexicanos |work|
Si desea profundizar en un aspecto específico de la regulación farmacéutica en México, por favor indíqueme si prefiere conocer los , los detalles del Suplemento para Farmacias , o cómo se tramita la adquisición del documento .
Farmacopea de los Estados Unidos Mexicanos (FEUM) is much more than a list of medicines; it is the official "scientific constitution" for health in Mexico, issued by the Ministry of Health. farmacopea de los estados unidos mexicanos
Mexico is one of just worldwide that possess their own national pharmacopoeia. This achievement provides scientific solidity and regulatory certainty for the nation's health system. The impact of the FEUM extends beyond its borders; it is recognized as an official reference in several Latin American countries, including El Salvador, Guatemala, Chile, Colombia, and Peru, making it a vital tool for public health in the Spanish-speaking world. Si desea profundizar en un aspecto específico de
This comprehensive guide explores the history, current structure, legal basis, and profound importance of the FEUM, establishing it as a fundamental pillar of Mexico's healthcare system. The flagship publication, consisting of over 4,000 pages,
The flagship publication, consisting of over 4,000 pages, which establishes standards for identity, purity, and quality for active pharmaceutical ingredients (APIs), excipients, and allopathic medicines, including biological and biotechnological products.
: Procedimientos analíticos estandarizados utilizados para verificar que una sustancia cumple con los criterios de calidad establecidos.
To ensure its continuous and expert-led development, the law created the (Permanent Commission of the FEUM). This body, which serves as a technical advisory organ to the Ministry of Health, is responsible for the elaboration, publication, and dissemination of the pharmacopoeia. The entire process of its review, updating, and edition is further governed by a specific legal framework, the Norma Oficial Mexicana NOM-001-SSA1-2020 , which ensures transparency and rigor in its creation. This official backing, a point of pride, gives the FEUM a purely regulatory character, as its publications are priced only to recover operating costs, distinguishing it from pharmacopoeias in other nations that may operate as private or for-profit entities.